Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Frontline Treatment with Ibrutinib with Rituximab (IR) Combination Is Highly Effective in Elderly (≥65 years) Patients with Mantle Cell Lymphoma (MCL) - Results from a Phase II Trial

Blood (2019) 134 (Supplement_1): 3988.

https://doi.org/10.1182/blood-2019-125800

Published: 2019

Journal Articles

Interleukin-6 Adversely Impacts Genomic Stability Via Targeting Multiple Pathways in Multiple Myeloma

Chaitanya Yenumula, MD, Srikanth Talluri, PhD, Tommaso Perini, MD, Subodh Kumar, PhD, Jialan Shi, MD PhD, Rao Prabhala, PhD, Masood A. Shammas, PhD, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 4467.

https://doi.org/10.1182/blood-2018-99-119346

Published: 2018

Journal Articles

A Twenty Years Epidemiology Study of 2 nd Hematological Malignancies Post to the Initial Tumor Treatment: Report from Southern China Single Cancer Group

Siliang Chen, Zheyuan Qin, Stephen Liang, MD

Blood (2018) 132 (Supplement 1): 5903.

https://doi.org/10.1182/blood-2018-99-118481

Published: 2018

Journal Articles

The Potential of Using DNA Damage Repair Deficiency As a Biomarker for Cytarabine Response in AML Patients

Clare Crean, BA, MSc, Kienan I Savage, PhD, Ken I Mills, PhD FRCPath, BSc

Blood (2018) 132 (Supplement 1): 2812.

https://doi.org/10.1182/blood-2018-99-115854

Published: 2018

Journal Articles

Saliva-Omics in Plasma Cell Disorders — Proof of Concept and Potential As a Non-Invasive Tool for Monitoring Disease Burden and MRD Status

Ciara Tierney, BSc, Despina Bazou, BSc, MSc, PhD, Giao Le, BA (Hons), MB BCh, MRCPI, Paul Dowling, BSc, PhD, Peter O'Gorman, MD PhD FRCP, FRCPath

Blood (2018) 132 (Supplement 1): 3177.

https://doi.org/10.1182/blood-2018-99-110166

Published: 2018

Journal Articles

Late Effects of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) in Elderly Patients with Lymphoma

Parastoo B. Dahi, MD, Chikaodi Obioha, Sheila Kenny, NP, Patrick Hilden, MS, Molly Maloy, MS, Alexander Geyer, MD, Wendy Schaffer, MD, Roni Tamari, MD, Craig S. Sauter, MD, Ann A. Jakubowski, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 4620.

https://doi.org/10.1182/blood-2018-99-112632

Published: 2018

Journal Articles

Impact of Iron Deficiency Anemia on Inpatient Mortality, Hospital Cost, and Length of Stay in Patients with Luminal Gastrointestinal Cancers: Data from the Healthcare Cost and Utilization Project from 1999-2014

Praneeth Baratam, MD, Erika Correa, MD MS, Stuthi Perimbeti, MD MPH, Michael Styler, MD, David Topolsky, MD, Pamela Ann Crilley, DO, Maneesh Jain, MD, Kristine Ward, MD

Blood (2017) 130 (Supplement 1): 4669.

https://doi.org/10.1182/blood.V130.Suppl_1.4669.4669

Published: 2017

Journal Articles

The Role and Mechanism of PTPN21 Isoforms in Acute Lymphoblastic Leukemia Escaping NK Cell Killing

Huafang Wang, PhD, Ni Zhu, Binsheng Wang, Limengmeng Wang, Xiaohong Yu, He Huang, MD

Blood (2017) 130 (Supplement 1): 2569.

https://doi.org/10.1182/blood.V130.Suppl_1.2569.2569

Published: 2017

Journal Articles

Do Sequential Compression Devices Prevent Venous Thromboembolism in Hospital Inpatients?

Prajwal Dhakal, MBBS, Shiva Shrotriya, MBBS, Mukta Sharma, MBBS, Anas Al-Janadi, MD, Ling Wang, PhD, Supratik Rayamajhi, MD

Blood (2017) 130 (Supplement 1): 2084.

https://doi.org/10.1182/blood.V130.Suppl_1.2084.2084

Published: 2017

Journal Articles

Surgery in Patients with Factor VIII Inhibitors: A Retrospective Case Series at the Largest Canadian Hemophilia Care Centre

Aditi Khandelwal, MDM, Syed Mahamad, BSc candidate, Jerome M. Teitel, MD, Michelle Sholzberg, MDM, MSc

Blood (2016) 128 (22): 1418.

https://doi.org/10.1182/blood.V128.22.1418.1418

Published: 2016

Journal Articles

Prevalence and Risk Predictive Factors of Comorbid Malignancies in Patients with Chronic Myeloid Leukemia

Tong-Yoon Kim, MD, Sung-Eun Lee, Soo-Hyun Kim, Soo-Young Choi, Eun-Jung Jang, Dong-Wook Kim, MD PhD

Blood (2016) 128 (22): 1900.

https://doi.org/10.1182/blood.V128.22.1900.1900

Published: 2016

Journal Articles

A Randomized Study of Cyclosporine and Methotrexate with or without Methylprednisolone for the Prevention of Graft-Versus-Host Disease: Improved Long-Term Survival with the Triple Prophylaxis

Tapani Ruutu, MD PhD, Anne Nihtinen, MD PhD, Riitta Niittyvuopio, MD PhD, Eeva Juvonen, MD PhD, Liisa Volin, MD PhD

Blood (2016) 128 (22): 2241.

https://doi.org/10.1182/blood.V128.22.2241.2241

Published: 2016

Journal Articles

Venous and Arterial Thromboembolism Related Hospitalizations Among Patients with Gastrointestinal Malignancy in United States - Data from Nationwide Sample

Chaitanya Puligondla, MBBS, Rachit Kumar, MD, Sravanthi Parasa, MD

Blood (2016) 128 (22): 4993.

https://doi.org/10.1182/blood.V128.22.4993.4993

Published: 2016

Journal Articles

A Homozygous Germ Line Nonsense Mutation in BRCA1 Leading Fanconi Anemia and Neuroblastoma

Demirel Mehmet, Sule Unal, Fatma Gumruk, Nurten Ayse Akarsu

Blood (2016) 128 (22): 5073.

https://doi.org/10.1182/blood.V128.22.5073.5073

Published: 2016

Journal Articles

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Gary H. Lyman, MD MPH, Eva Culakova, PhD MS, Marek S. Poniewierski, MD MS, MS, Nicole M. Kuderer, MD

Blood (2016) 128 (22): 4751.

https://doi.org/10.1182/blood.V128.22.4751.4751

Published: 2016

Journal Articles

Secondary Cancer after Allogeneic Hematopoietic Stem Cell Transplantation

Yosuke Tanaka, MD, Saiko Kurosawa, MD, Kinuko Tajima, Yoshihiro Inamoto, MD PhD, Reiko Ito, MD, Takashi Tanaka, MD, Yoshitaka Inoue, MD, Takayuki Ozawa, MD, Akihisa Kawajiri, MD, Akio Onishi, MD, Keiji Okinaka, MD, Shigeo Fuji, MD, Sung-Won Kim, MD, Ryuji Tanosaki, MD PhD, Takuya Yamashita, MD PhD, Takahiro Fukuda, MD

Blood (2015) 126 (23): 3162.

https://doi.org/10.1182/blood.V126.23.3162.3162

Published: 2015

Journal Articles

High Incidence of Secondary Malignancies after Reduced Intensity Allo-SCT: Results of a Single-Center Study with Extended Follow-up

Jeremy Delage, Stephane Vigouroux, Reza Tabrizi, Catherine Mohr, Pascal Turlure, MD, Noel Milpied

Blood (2015) 126 (23): 4353.

https://doi.org/10.1182/blood.V126.23.4353.4353

Published: 2015

Journal Articles

Specific Exosomal microRNA Are Differentially Expressed Between High and Low-Risk Myeloma Suggesting They Are Pathogenically Important

Bangzheng Chen, PhD, Gareth J Morgan, MDPhD, Bart Barlogie, MD PhD, Joshua Epstein, DSc

Blood (2015) 126 (23): 4189.

https://doi.org/10.1182/blood.V126.23.4189.4189

Published: 2015

Journal Articles

NK Cell Line Killing of Leukemia Cells Is Enhanced By Reverse Antibody Dependent Cell Mediated Cytotoxicity (R-ADCC) Via NKp30 and NKp44 and Target Fcγ Receptor II (CD32)

Brent A. Williams, MD, Xinghua Wang, MD, Bertrand Routy, MD, Richard Cheng, BSc, Sonam Maghera, BSc, Armand Keating, MD

Blood (2014) 124 (21): 2444.

https://doi.org/10.1182/blood.V124.21.2444.2444

Published: 2014

Journal Articles

Autoimmune Hemolytic Anemia In Cancer Patients At a Tertiary Center In Southern Nigeria

Kaladada I. Korubo, MBBS, FMCPATH, Chijioke A. Nwauche, MBBS, FWACP, Oseikhuemen A. Ejele, MBBS, FWACP, FMCPATH

Blood (2013) 122 (21): 4658.

https://doi.org/10.1182/blood.V122.21.4658.4658

Published: 2013

NARROW

Frontline Treatment with Ibrutinib with Rituximab (IR) Combination Is Highly Effective in Elderly (≥65 years) Patients with Mantle Cell Lymphoma (MCL) - Results from a Phase II Trial

Interleukin-6 Adversely Impacts Genomic Stability Via Targeting Multiple Pathways in Multiple Myeloma

A Twenty Years Epidemiology Study of 2 nd Hematological Malignancies Post to the Initial Tumor Treatment: Report from Southern China Single Cancer Group

The Potential of Using DNA Damage Repair Deficiency As a Biomarker for Cytarabine Response in AML Patients

Saliva-Omics in Plasma Cell Disorders — Proof of Concept and Potential As a Non-Invasive Tool for Monitoring Disease Burden and MRD Status

Late Effects of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) in Elderly Patients with Lymphoma

Impact of Iron Deficiency Anemia on Inpatient Mortality, Hospital Cost, and Length of Stay in Patients with Luminal Gastrointestinal Cancers: Data from the Healthcare Cost and Utilization Project from 1999-2014

The Role and Mechanism of PTPN21 Isoforms in Acute Lymphoblastic Leukemia Escaping NK Cell Killing

Do Sequential Compression Devices Prevent Venous Thromboembolism in Hospital Inpatients?

Surgery in Patients with Factor VIII Inhibitors: A Retrospective Case Series at the Largest Canadian Hemophilia Care Centre

Prevalence and Risk Predictive Factors of Comorbid Malignancies in Patients with Chronic Myeloid Leukemia

A Randomized Study of Cyclosporine and Methotrexate with or without Methylprednisolone for the Prevention of Graft-Versus-Host Disease: Improved Long-Term Survival with the Triple Prophylaxis

Venous and Arterial Thromboembolism Related Hospitalizations Among Patients with Gastrointestinal Malignancy in United States - Data from Nationwide Sample

A Homozygous Germ Line Nonsense Mutation in BRCA1 Leading Fanconi Anemia and Neuroblastoma

Morbidity, Mortality and Costs Associated with Venous Thromboembolism in Hospitalized Patients with Cancer

Secondary Cancer after Allogeneic Hematopoietic Stem Cell Transplantation

High Incidence of Secondary Malignancies after Reduced Intensity Allo-SCT: Results of a Single-Center Study with Extended Follow-up

Specific Exosomal microRNA Are Differentially Expressed Between High and Low-Risk Myeloma Suggesting They Are Pathogenically Important

NK Cell Line Killing of Leukemia Cells Is Enhanced By Reverse Antibody Dependent Cell Mediated Cytotoxicity (R-ADCC) Via NKp30 and NKp44 and Target Fcγ Receptor II (CD32)

Autoimmune Hemolytic Anemia In Cancer Patients At a Tertiary Center In Southern Nigeria

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only